美国FDA药品DMF数据库
(U.S. FDA Drug Master Files)
DMF号码 DMF状态 DMF类型 提交日期 持有人 关联主题/药物名称
39944 A II 2025/01/07 HUBEI HONCH PHARMACEUTICAL CO LTD VINBLASTINE SULFATE NON-STERILE, BULK DRUG SUBSTANCE
40908 A II 2025/01/07 RECORDATI INDUSTRIA CHIMICA AND FARMACEUTICA SPA OSILODROSTAT PHOSPHATE
41057 A II 2025/01/07 MEGHMANI LLP ACETAMINOPHEN/PARACETAMOL GRANULES DC 90% (DIRECTOACE-90F)
41164 A III 2025/01/06 GUANGDONG HECHUANG PRECISION PHARMA PACKAGING CO LTD NASAL SPRAYER, ORAL SPRAYER, TOPICAL SPRAYER, EAR SPRAYER ; DROPPER AND CAP; BOTTLES; PUMPS;SPRAYER
41169 A II 2025/01/06 SHENZHEN JYMED TECHNOLOGY CO LTD TERIPARATIDE
38046 A II 2025/01/06 ALKEM LABORATORIES LTD ESLICARBAZEPINE ACETATE
40960 A II 2025/01/06 RAKSHIT DRUGS PVT LTD ACETYL DAPAGLIFLOZIN / TETRA ACETYL DAPAGLIFLOZIN
40980 A II 2025/01/06 HUNAN OUYA PHARMACEUTICAL CO LTD TAFAMIDIS MEGLUMINE DRUG SUBSTANCE
41097 A II 2025/01/06 ORIGINCELL BIOTECHNOLOGY CO LTD HUMAN MESENCHYMAL STEM CELL
41144 A II 2025/01/05 WISDOM PHARMACEUTICAL CO LTD EXATECAN MESYLATE
40833 A II 2025/01/05 MEGAFINE PHARMA P LTD APIXABAN (NON-STERILE DRUG SUBSTANCE)
41076 A II 2025/01/05 SHENZHEN READLINE BIOTECH CO LTD SEMAGLUTIDE MAIN CHAIN
40500 A II 2025/01/04 MACLEODS PHARMACEUTICALS LTD RIFAXIMIN
40885 A II 2025/01/04 SYNTHIMED LABS PRIVATE LTD EZETIMIBE USP
41162 A IV 2025/01/03 ZHEJIANG KINGLAND PHARMACEUTICAL CO LTD ANHYDROUS CITRIC ACID
40804 A II 2025/01/03 VALARY LAB LTD CABOZANTINIB MALATE (FORM-N2)
41036 A II 2025/01/03 SUZHOU MOTIF BIOTECH CO LTD TIRZEPATIDE
41059 A II 2025/01/03 MEGHMANI LLP ACETAMINOPHEN USP
41094 A II 2025/01/03 CHANGZHOU PHARMACEUTICAL FACTORY VALSARTAN
41163 A II 2025/01/02 SHAOXING JINGXIN PHARMACEUTICALS CO LTD APIXABAN

数据库说明:

当前数据更新日期:2025年10月13日(该库为每季度更新),更多信息请点击此处查询美国FDA药品数据库
©2006-2025 DrugFuture->U.S. FDA Drug Master Files